Back to results
US 2008/0305074 A1Published application
Stem cell factor
AssigneeAmgen Inc.
InventorsKrisztina M. Zsebo, Robert A. Bosselman, Sidney V. Suggs, Francis H. Martin
Life of this patent
Estimating the term…
Abstract
Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
Claims20
1-70. (canceled)
A method of treating a hematopoietic disorder characterized by reduction in bone marrow mass, comprising the step of administering to a human an effective amount of a human stem cell factor (SCF) polypeptide and optionally a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.